Patent assignee · CA · COMPANY

RSEM, LIMITED PARTNERSHIP

14Patents
14Active
14Granted
50Portfolio score

Filing activity: Nov 14, 2007 → Apr 23, 2021 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9232976B2 Magnetic interference reducing surgical drape Human Necessities 13 Active
US7971998B2 Apparatus and method for measuring a displacement within an eye in vivo in situ, and method of assessment Human Necessities 9 Active
US9757378B2 Methods to modulate acute myeloid leukemia stem/progenitor cell expansion and/or differentiation Physics 1 Active
US8039436B2 Mutated HOXB4 proteins with improved stability, and methods of use thereof Human Necessities 1 Active
US8993515B2 Peptidomimetics comprising N-amino cyclic urea residues and uses thereof Emerging Cross-Sectional Technologies 1 Active
US10414813B2 Minor histocompatibility antigens and uses thereof Physics 0 Active
US10766964B2 Compositions and methods for treating and preventing inflammation Chemistry; Metallurgy 0 Active
US12031137B2 Compositions comprising SASP modulators and senescence attenuators and uses thereof for modulating cellular senescence Chemistry; Metallurgy 0 Active
US11268097B2 Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability Physics 0 Active
US9822367B2 Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability Physics 0 Active
US9102981B2 Assessment and reduction of risk of graft-versus-host disease Physics 0 Active
US10738122B2 Compositions and methods for treating and preventing inflammation Chemistry; Metallurgy 0 Active
US11649292B2 Compositions and methods for treating and preventing inflammation Chemistry; Metallurgy 0 Active
US10612028B2 Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability Physics 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.